Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,333 across all filing types
Latest filing 2010-04-27 Board/Management Inform…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Åse Aulie Michelet foreslås som nytt styremedlem i Photocure
Board/Management Information Classification · 100% confidence The document announces a proposal by the nomination committee to appoint a new board member (Åse Aulie Michelet) to the board of directors of Photocure ASA. It details the candidate's background and the committee's rationale for the appointment. This falls under the category of board/management information, specifically regarding changes or nominations to the board.
2010-04-27 Norwegian
Photocure ASA - Kjøp av egne aksjer
Transaction in Own Shares Classification · 100% confidence The document is a short announcement from Photocure ASA regarding the purchase of its own shares (tilbakekjøp av aksjer) on April 26, 2010. It specifies the number of shares purchased and the average price, which directly aligns with the definition for 'Transaction in Own Shares' (POS).
2010-04-27 Norwegian
Photocure ASA - Notification of trade
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the company's purchase of its own shares as part of a share buyback program. It specifies the number of shares bought, the average price, and the updated total of treasury shares held. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2010-04-27 English
Photocure ASA - Invitasjon til presentasjon av resultater første kvartal 2010
Regulatory Filings Classification · 95% confidence The document is an invitation to a presentation of the company's first-quarter 2010 results. It is short (under 5,000 characters), does not contain the actual financial results, and serves as an announcement regarding the timing and location of the upcoming earnings presentation. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2010-04-26 Norwegian
Photocure ASA - Presentation of the 1st quarter 2010 report
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2179 characters) notifying stakeholders about the upcoming presentation of the 1st quarter 2010 report. It provides details on the time, location, and registration for the event, rather than containing the financial report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2010-04-26 English
Photocure ASA - Kjøp av egne aksjer
Transaction in Own Shares Classification · 100% confidence The document is a short announcement regarding the company's purchase of its own shares (share buyback) as part of a repurchase program. It specifies the number of shares purchased, the average price, and the updated total of treasury shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2010-04-26 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.